# Andson Biotech Inc. — Form D

Andson Biotech Inc. of ATLANTA, GA, a company, filed a Form D exempt-offering notice with the SEC on 2024-03-26. The offering totals $3.6M, of which $3.6M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2024-03-26
- Form: D
- Accession: 0002017131-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.6M
- Amount sold: $3.6M
- Minimum investment: $5K
- Investors: 37
- Date of first sale: 2024-03-12
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-508686

## Issuer

- Name: Andson Biotech Inc.
- CIK: 0002017131
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 1705 COMMERCE DR NW, ATLANTA, GA, 30318
- Phone: 7273897725

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| Andrei Fedorov | Director | Atlanta, GA |
| Mason Chilmonczyk | Director | Atlanta, GA |
| Mason Chilmonczyk | Executive Officer | Atlanta, GA |
| Jim Filippini | Executive Officer | Atlanta, GA |
| Thomas O'Brien | Director | Jersey City, NJ |
| Glenn Epstein | Director | Atlanta, GA |
| James Ross | Director | Metairie, LA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2025-10-22](https://search.stillhousedata.com/formd/0002017131-25-000004) | D | $5.0M | $4.7M |

## More

- [CIK 2017131 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2017131&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002017131-24-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.